Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

Louapre, Céline; Collongues, Nicolas; Stankoff, Bruno; Giannesini, C.; Papeix, Caroline; Bensa, Caroline; Deschamps, Romain; Créange, Alain; Wahab, Abir; Pelletier, Jean; Heinzlef, Olivier; Labauge, Pierre; Guilloton, L.; Ahle, Guido; Goudot, Mathilde; Bigaut, Kévin; Laplaud, David; Vukusic, Sandra; Lubetzki, Catherine; Sèze, de; the Covisep investigators, for

doi:10.1001/jamaneurol.2020.2581

Public

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

Published in JAMA Neurology • Jun 26, 2020

Authors:

Céline Louapre

Nicolas Collongues

Bruno Stankoff

Abstract

Importance: Risk factors associated with the severity of coronavirus disease 2019 (COVID-19) in patients with multiple sclerosis (MS) are unknown. Disease-modifying therapies (DMTs) may modify the risk of developing a severe COVID-19 infection, beside identified risk factors such as age and comorbid...

Subject

Medicine

Retrospective cohort study

Comorbidity

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!